ArticleClinical epigenetics2024

Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax.

Danyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.